Maartje van den biggelaar

Principal investigator
Molecular Hematology, Sanquin Research, Amsterdam, The Netherlands
Amsterdam, Noord-Holland, Netherlands

Presentation(s):

• PB0278 - Current practice regarding Bleeding Disorder of Unknown Cause (BDUC) in the Netherlands: a national survey

  Sunday, June 23, 2024
  13:45 – 14:45 ICT

• PB0285 - Diagnosing and treating Bleeding Disorder of Unknown Cause: an illustrated review on current practice and future directions

  Sunday, June 23, 2024
  13:45 – 14:45 ICT

• PB0341 - Impaired secretion of Von Willebrand Factor in patients with biallelic mutations in the guanine nucleotide exchange factor MADD

  Sunday, June 23, 2024
  13:45 – 14:45 ICT

• OC 27.1 - Dominant negative effects of Gln50Arg mutation in the EGF-1 domain of factor IX causes severe Hemophilia B affecting factor IX replacement therapy

  Sunday, June 23, 2024
  14:45 – 15:00 ICT

• OC 37.1 - Advanced hemostasis testing by quantitative proteomics

  Monday, June 24, 2024
  09:30 – 09:45 ICT

• PB0851 - Quantitative mass spectrometry-based monitoring of site-specific citrullination of fibrinogen

  Monday, June 24, 2024
  13:45 – 14:45 ICT

• PB0839 - Unravelling the molecular dynamics of endothelial inflammation states interplay from a proteomic perspective

  Monday, June 24, 2024
  13:45 – 14:45 ICT